학술논문

Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study.
Document Type
Article
Source
BMC Pharmacology & Toxicology; 12/13/2023, Vol. 24 Issue 1, p1-9, 9p
Subject
PROPENSITY score matching
WARFARIN
APIXABAN
RIVAROXABAN
VENOUS thrombosis
THROMBOEMBOLISM
ANTICOAGULANTS
Language
ISSN
20506511
Abstract
Copyright of BMC Pharmacology & Toxicology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)